GGrantIndex
← Leaderboards

Christopher J McDougle

Indiana Univ-Purdue Univ At Indianapolis

Google Scholar ↗PubMed ↗ORCID ↗
$5,874,993
Attributed
$5,874,993
Total exposure
17
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $875K · FY2005–13
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$5,874,993 · 17

By mechanism

R01$2,989,252 · 3
U10$2,724,660 · 1
M01$161,081 · 12
N01$0 · 1

Top collaborators

No co-investigators on record.

Most similar at Indiana Univ-Purdue Univ At Indianapolis

Same institution · by research overlap

Others in their field

Top investigators on “Child”

Research focus

ChildAutistic DisorderBehaviorAdolescentRandomizedPharmaceutical PreparationsResponseRisperidonePlacebosAffectDisabilityMonitorAntipsychotic AgentsDouble-Blind MethodAdverse EffectsFundingResearch PersonnelBehavior TherapyWeekClinical TrialsAggressive BehaviorPublic Health Medicine (Field)MedicalAripiprazole

Grant awards (32)

1/4-RUPP Autism Network: Guanfacine for the Treatment of Hyperactivity in PDD$1
R01 · FY2013 · MH · contact PI
Targeted Pharmacologic Interventions for Autism$217,870
R01 · FY2011 · MH · contact PI
1/4-RUPP Autism Network: Guanfacine for the Treatment of Hyperactivity in PDD$178,386
R01 · FY2011 · MH · contact PI
1/4-RUPP Autism Network: Guanfacine for the Treatment of Hyperactivity in PDD$158,789
R01 · FY2011 · MH · contact PI
Targeted Pharmacologic Interventions for Autism$145,618
R01 · FY2011 · MH · contact PI
Targeted Pharmacologic Interventions for Autism$370,481
R01 · FY2010 · MH · contact PI
1/4-RUPP Autism Network: Guanfacine for the Treatment of Hyperactivity in PDD$366,035
R01 · FY2010 · MH · contact PI
Novel Pharmacological Strategies in Autism$305,254
R01 · FY2009 · MH · contact PI
Novel Pharmacological Strategies in Autism$305,254
R01 · FY2008 · MH · contact PI
RISPERIDONE AND BEHAVIOR THERAPY IN CHILDREN AND ADOLESCENTS WITH PERVASIVE D$3,446
M01 · FY2008 · RR · contact PI
NOVEL PHARMACOLOGICAL STRATEGIES IN AUTISM$1,585
M01 · FY2008 · RR · contact PI
ARIPIPRAZOLE IN CHILDREN AND ADOLESCENTS WITH AUTISTIC DISORDER$1,338
M01 · FY2008 · RR · contact PI
Novel Pharmacological Strategies in Autism$305,254
R01 · FY2007 · MH · contact PI
RISPERIDONE AND BEHAVIOR THERAPY IN CHILDREN AND ADOLESCENTS WITH PERVASIVE D$40,557
M01 · FY2007 · RR · contact PI
NOVEL PHARMACOLOGICAL STRATEGIES IN AUTISM$18,654
M01 · FY2007 · RR · contact PI
ARIPIPRAZOLE IN CHILDREN AND ADOLESCENTS WITH AUTISTIC DISORDER$15,743
M01 · FY2007 · RR · contact PI
RUPP-PI$504,905
U10 · FY2006 · MH · contact PI
Novel Pharmacological Strategies in Autism$314,372
R01 · FY2006 · MH · contact PI
RISPERIDONE AND BEHAVIOR THERAPY IN CHILDREN AND ADOLESCENTS WITH PERVASIVE D$44,038
M01 · FY2006 · RR · contact PI
ARIPIPRAZOLE IN CHILDREN AND ADOLESCENTS WITH AUTISTIC DISORDER$11,110
M01 · FY2006 · RR · contact PI
NOVEL PHARMACOLOGICAL STRATEGIES IN AUTISM$606
M01 · FY2006 · RR · contact PI
RUPP-PI$504,888
U10 · FY2005 · MH
Novel Pharmacological Strategies in Autism$321,938
R01 · FY2005 · MH
RISPERIDONE AND BEHAVIOR THERAPY IN CHILDREN AND ADOLESCENTS WITH PERVASIVE D$10,824
M01 · FY2005 · RR
RG1068 (SYNTHETIC HUMAN SECRETIN) IN CHILDREN WITH AUTISM$221
M01 · FY2005 · RR
RUPP-PI$489,712
U10 · FY2004 · MH
Methylphenidate in the Rx of Hyperactivity &Impulsiveness in Children w/PDD$7,227
M01 · FY2004 · RR
RG1068 (Synthetic Human Secretin) in Children with Autism$5,732
M01 · FY2004 · RR
RUPP-PI$475,621
U10 · FY2003 · MH
RUPP-PI$301,000
U10 · FY2003 · MH
RESEARCH UNITS ON PEDIATRIC PSYCHOPHARMACOLOGY--AUTISM-278970001$0
N01 · FY2003 · MH
RUPP-PI$448,534
U10 · FY2002 · MH